← Eichor
Condition: Ntrk Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ntrk

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Xuanzhu Biopharmaceutical Co., Ltd. · NCT04996121NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and S
Phase 1/Phase 2 · 7 location(s) · St. Jude Children's Research Hospital · NCT06239272Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi
Phase N/A · 76 location(s) · Bayer · NCT04142437A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · 165 location(s) · Turning Point Therapeutics, Inc. · NCT03093116A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTR
Phase 1/Phase 2 · 6 location(s) · Cullgen (Shanghai),Inc · NCT07394374NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes
Phase N/A · 1 location(s) · Bayer · NCT04945330Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
Phase 1/Phase 2 · 1 location(s) · Beijing InnoCare Pharma Tech Co., Ltd. · NCT05745623Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Phase 2 · 5 location(s) · Children's Hospital of Philadelphia · NCT05783323Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: RO
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT01639508A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
EARLY_Phase 1 · 21 location(s) · Nationwide Children's Hospital · NCT04655404A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 · 5 location(s) · Avistone Biotechnology Co., Ltd. · NCT06716138Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04879121A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
Phase 2 · 19 location(s) · Teligene US · NCT06010342A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 · 15 location(s) · Avistone Biotechnology Co., Ltd. · NCT06307795
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.